Liposomal-all-trans-retinoic acid in treatment of acute promyelocytic leukemia

Keyphrases

• All-trans Retinoic Acid 100%
• Liposomal 100%
• Acute Promyelocytic Leukemia 100%
• LiPo 29%
• Plasma Drug Concentration 11%
• Newly Diagnosed Patients 11%
• Molecular Remission 11%
• Liver 5%
• Metabolism 5%
• Chemotherapy 5%
• Plasma Concentration 5%
• Remission 5%
• Oral Administration 5%
• Pharmacokinetic Profile 5%
• Drug Levels 5%
• Phase I Clinical Trial 5%
• Previously Treated 5%
• Clinical Remission 5%
• Intravenous Administration 5%
• Drug Metabolism 5%
• Induced Effect 5%
• Leukemia Disease 5%
• Pharmacological Attributes 5%
• Retinoic Acid Resistance 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Retinoic Acid 100%
• Promyelocytic Leukemia 100%
• Remission 23%
• Drug Concentration 11%
• Pharmacokinetic 5%
• Diseases 5%
• Clinical Study 5%
• Chemotherapy 5%
• Side Effect 5%
• Drug Metabolism 5%
• Acid 5%